Lunai Bioworks Inc. financial data

Symbol
LNAI on Nasdaq
Location
Suite 906 Los Angeles, CA
Fiscal year end
30 June
Latest financial report
10-Q - Q4 2025 - 17 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 6.2% % -7.7%
Debt-to-equity 245% % 756%
Return On Equity -67% % 53%
Return On Assets -360% % -309%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 24,187,356 shares -85%
Common Stock, Shares, Outstanding 24,187,356 shares -85%
Entity Public Float $111,903,627 USD 96%
Common Stock, Value, Issued $2,419 USD -85%
Weighted Average Number of Shares Outstanding, Basic 23,482,714 shares 45%
Weighted Average Number of Shares Outstanding, Diluted 23,482,714 shares 45%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $45,872 USD -72%
General and Administrative Expense $12,402,402 USD -44%
Operating Income (Loss) $136,212,906 USD -7.8%
Nonoperating Income (Expense) $10,689,464 USD 5714%
Net Income (Loss) Attributable to Parent $125,523,442 USD 0.52%
Earnings Per Share, Basic 2.18 USD/shares 82%
Earnings Per Share, Diluted 2.18 USD/shares 82%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $491,645 USD 58%
Accounts Receivable, after Allowance for Credit Loss, Current $964,389 USD
Assets, Current $514,489 USD -70%
Property, Plant and Equipment, Net $13,253 USD -97%
Operating Lease, Right-of-Use Asset $687,371 USD -46%
Goodwill $5,963,000 USD -94%
Other Assets, Noncurrent $6,138,704 USD -94%
Assets $6,666,446 USD -94%
Accounts Payable, Current $167,259 USD
Accrued Liabilities, Current $4,927,474 USD -11%
Liabilities, Current $20,001,577 USD -30%
Operating Lease, Liability, Noncurrent $213,657 USD -68%
Other Liabilities, Noncurrent $271,643 USD 17%
Liabilities $20,215,234 USD -31%
Accumulated Other Comprehensive Income (Loss), Net of Tax $139,023 USD 96%
Retained Earnings (Accumulated Deficit) $509,442,953 USD -33%
Stockholders' Equity Attributable to Parent $13,548,788 USD -117%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $88,386,851 USD -34%
Liabilities and Equity $6,666,446 USD -94%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,349,110 USD 33%
Net Cash Provided by (Used in) Financing Activities $1,343,357 USD -34%
Net Cash Provided by (Used in) Investing Activities $544,700 USD
Common Stock, Shares Authorized 350,000,000 shares 0%
Common Stock, Shares, Issued 24,187,356 shares -85%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $532,108 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $491,645 USD 58%
Interest Paid, Excluding Capitalized Interest, Operating Activities $8,559 USD
Deferred Tax Assets, Valuation Allowance $83,680,863 USD -51%
Depreciation $113,563 USD 5.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $121,814,862 USD 6.3%
Lessee, Operating Lease, Liability, to be Paid $737,593 USD -45%
Property, Plant and Equipment, Gross $1,070,023 USD 0.9%
Operating Lease, Liability, Current $274,983 USD -51%
Lessee, Operating Lease, Liability, to be Paid, Year Two $358,326 USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year One $363,999 USD -34%
Operating Lease, Weighted Average Discount Rate, Percent 0.0466 pure -9.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $41,353 USD -55%
Lessee, Operating Lease, Liability, to be Paid, Year Three $334,788 USD 28%
Deferred Tax Assets, Operating Loss Carryforwards $76,296,814 USD -49%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $309,491 USD
Operating Lease, Payments $108,441 USD 9.6%
Additional Paid in Capital $496,030,769 USD 5.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $8,296 USD 34%
Depreciation, Depletion and Amortization $117,455 USD -6.7%
Interest Expense $303,802 USD 148%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%